| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 05/21/2004 | WO2004042049A1 Method of degrading hardly degradable protein |
| 05/21/2004 | WO2004041826A1 Imidazopyrazinones and imidazotriazinones derivates as gaba-a receptor anxiolytic |
| 05/21/2004 | WO2004041814A1 Heteroaryl-pyramidine derivatives as jak inhibitors |
| 05/21/2004 | WO2004041808A1 4-imidazol-1-ylmethyl-pyrimidine derivatives_as ligands for gabaa receptors |
| 05/21/2004 | WO2004041802A1 4(phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain or gastrointestinal disorders |
| 05/21/2004 | WO2004041801A1 4(phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain or gastrointestinal disorders |
| 05/21/2004 | WO2004041800A1 4(phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain or gastrointestinal disorders |
| 05/21/2004 | WO2004041794A1 Antiinflammatory 3-arylthio-3-thiazolyl-alkylamines |
| 05/21/2004 | WO2004041793A1 Phenylalkyl and pyridylalkyl piperazine derivatives |
| 05/21/2004 | WO2004041792A1 Substituted benzoxazinones and uses thereof |
| 05/21/2004 | WO2004041784A1 Phenyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain or gastrointestinal disorders |
| 05/21/2004 | WO2004041304A2 Pain relief agents |
| 05/21/2004 | WO2004041282A1 Receptor regulator |
| 05/21/2004 | WO2004041281A1 Treatment of hyperkinetic movement disorder with donepezil |
| 05/21/2004 | WO2004041271A1 Oromucosal formulation and process for preparing the same |
| 05/21/2004 | WO2004041269A2 New use for pharmaceutical composition |
| 05/21/2004 | WO2004041266A1 Receptor function controlling agent |
| 05/21/2004 | WO2004041258A2 Cyclic nucleotide phosphodiesterase inhibitors, preparation and uses |
| 05/21/2004 | WO2004041245A2 Pharmaceutical solutions comprising a modafinil compound and their use for the manufacture of a medicament for treating different diseases |
| 05/21/2004 | WO2004041212A2 Apkc isoforms in nervous system disorders and cancer |
| 05/21/2004 | WO2004041067A2 Prevention and treatment of synucleinopathic disease |
| 05/21/2004 | WO2004022558A3 Hydroxy alkyl substituted 1,3,8-triazaspiro[4.5]decan-4-one derivatives useful for the treatment of orl-1 receptor mediated disorders |
| 05/21/2004 | WO2004022528A3 Arylglycine derivatives and their use as glycine transport inhibitors |
| 05/21/2004 | WO2004018473A3 Azapurine derivatives |
| 05/21/2004 | WO2004016244A3 Pharmaceutical compositions for buccal delivery of pain relief medications |
| 05/21/2004 | WO2004000817A3 Benzimidazole compounds and their use as estrogen agonists/antagonists |
| 05/21/2004 | WO2003104426A3 Isolated nucleic acid molecule encoding a novel centromere-associated motor protein, and uses thereof |
| 05/21/2004 | WO2003101455A3 Pharmaceutically active compounds having a tricyclic pyrazolotriazolopyrimidine ring structure and methods of use |
| 05/21/2004 | WO2003088900A3 Solid forms of salts with tyrosine kinase activity |
| 05/21/2004 | WO2003087403A3 Diagnostic and therapeutic use of a golgi protein for neurodegenerative diseases |
| 05/21/2004 | WO2003085110A3 Oligomeric compounds for the modulation hif-1alpha expression |
| 05/21/2004 | WO2003084935A3 Diaryl pyrimidinone derivatives useful for the treatment of inflammation and immunogolical diseases |
| 05/21/2004 | WO2003072543A3 Methods of preventing or treating brain ischemia or brain injury |
| 05/21/2004 | WO2003072040A3 Administration of agents for the treatment of inflammation |
| 05/21/2004 | WO2003055440A8 Compositions and methods for the treatement of immune related diseases |
| 05/21/2004 | WO2003042362A8 PGC-1β, A NOVEL PGC-1 HOMOLOGUE AND USES THEREFOR |
| 05/21/2004 | WO2003015780A8 Isoxazolopyridinones and use thereof in the treatment of parkinson's disease |
| 05/21/2004 | WO2002061105A8 Chimeric molecules containing a module able to target specific cells and a module regulating the apoptogenic function of the permeability transition pore complex (ptpc) |
| 05/21/2004 | WO2002060435A8 Cryptotanshinone for preventing and alleviating alzheimer's disease |
| 05/21/2004 | WO2002014467A8 Cng2b: a putative human cyclic nucleotide-gated ion channel |
| 05/21/2004 | WO2000066068A3 Method for inducing growth and enhancing survival of nervous tissue |
| 05/21/2004 | WO2000058340A3 50 human secreted proteins |
| 05/21/2004 | CA2543376A1 Interferon antagonists useful for the treatment of interferon related diseases |
| 05/21/2004 | CA2506773A1 Heteroaryl-pyramidine derivatives as jak inhibitors |
| 05/21/2004 | CA2505397A1 Phenylalkyl and pyridylalkyl piperazine derivatives |
| 05/21/2004 | CA2505334A1 Substituted benzoxazinones and uses thereof |
| 05/21/2004 | CA2505322A1 Receptor function regulator |
| 05/21/2004 | CA2504805A1 Receptor regulator |
| 05/21/2004 | CA2504802A1 Pharmaceutical composition comprising cannabinoids for the treatment of pain and sleep disorders |
| 05/21/2004 | CA2504350A1 Apkc isoforms in nervous system disorders and cancer |
| 05/21/2004 | CA2503964A1 Pain relief agents |
| 05/21/2004 | CA2503716A1 Cyclic nucleotide phosphodiesterase inhibitors, preparation and uses |
| 05/21/2004 | CA2503561A1 Prevention and treatment of synucleinopathic disease |
| 05/21/2004 | CA2503546A1 Pharmaceutical composition for preparing a medicine for treating and/or preventing a pathology related to an obsessive behaviour or obesity |
| 05/21/2004 | CA2502733A1 4(phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain or gastrointestinal disorders |
| 05/21/2004 | CA2502732A1 4(phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain or gastrointestinal disorders |
| 05/21/2004 | CA2495708A1 4-imidazol-1-ylmethyl-pyrimidine derivatives as ligands for gabaa receptors |
| 05/20/2004 | US20040097867 Systems and methods for treating patients with processed lipoaspirate cells |
| 05/20/2004 | US20040097739 Ppar delta activators |
| 05/20/2004 | US20040097733 Bicyclic aromatic or heteroaromatic-amine compounds; Regulators of cell proliferation and differentiation; useful for treating skin related diseases; retinoid antagonist or retinoid inverse agonist-like biological activity |
| 05/20/2004 | US20040097598 Method of treating neurological disorders using acetone derivatives |
| 05/20/2004 | US20040097589 Thyroid receptor ligands, pharmaceutical compositions comprising them and their use in the treatment of disorders influenced by thyroid hormones |
| 05/20/2004 | US20040097585 4-(2,6-difluorophenyl)-4-oxobutyric acid and derivatives; milder side effects; insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis, arteriosclerosis |
| 05/20/2004 | US20040097580 For therapy and prophylaxis of diseases or disorders induced by promotion of lipid peroxidation or accumulation of oxidized products |
| 05/20/2004 | US20040097578 4-Pyrrolidino-phenyl-benzyl ether derivatives |
| 05/20/2004 | US20040097577 Use of at least one of melatonin, a melatonin analogue, or a pharmaceutically acceptable salt of melatonin or melatonin analogue, in the preparation of a medicament for the treatment of ADHD in a mammal, especially a human being |
| 05/20/2004 | US20040097570 Novel benzimidazole derivatives and pharmaceutical compositions comprising these compounds |
| 05/20/2004 | US20040097569 Aryl substituted hydantoin compounds and their use as sodium channel blockers |
| 05/20/2004 | US20040097565 For therapy of pain associated with chronic inflammation or headache associated with hypertension |
| 05/20/2004 | US20040097551 As inhibitors of glucosylceramide synthase; for therapy and prophylaxis |
| 05/20/2004 | US20040097548 For prophylaxis and therapy of from inflammation, allergic disease, pain, migraine headache, neuralgia, itching, cough, central nervous system disease, digestive organs disease, nausea, emesis, urination disorder, circulatory disease |
| 05/20/2004 | US20040097544 Use of an inhibitor of the Na+/H+ exchanger for the production of a medicament for the treatment or prophylaxis of disturbances of the central nervous system |
| 05/20/2004 | US20040097540 Adenosine a2a receptor antangonists combined with neurotrophic activity compounds in the treatment of parkinson's disease |
| 05/20/2004 | US20040097539 Hsp inductor |
| 05/20/2004 | US20040097537 6-phenylbenzonaphthyridines |
| 05/20/2004 | US20040097526 Using triazolo(4,5-d)pyrimidine derivatives or a pharmaceutically acceptable salt or prodrug, in manufacture of a medicament for therapy or prevention of a disorder in which blocking of purine receptors may be beneficial |
| 05/20/2004 | US20040097524 For therapy and prophylaxis of disorder in which the blocking of purine receptors, particularly adenosine receptors and more may be beneficial, such a Parkinson's disease or depression, cognitive or memory impairment, pain |
| 05/20/2004 | US20040097513 Novel non-imidazole compounds |
| 05/20/2004 | US20040097508 Novel heterocyclically substituted amides, their preparation and use |
| 05/20/2004 | US20040097504 Compositions useful as inhibitors of jak and other protein kinases |
| 05/20/2004 | US20040097501 Triazole compounds useful as protein kinase inhibitors |
| 05/20/2004 | US20040097498 For prophylaxis and/or therapy of disorders of the urogenital system such as hypetrophy of the prostate, incontinence and in particular erectile dysfunction and female sexual dysfunction, cerebrovascular disorders |
| 05/20/2004 | US20040097497 4-heteroaryl-3-heteroarylidenyl-2-indolinones and their use as protein kinase inhibitors |
| 05/20/2004 | US20040097495 Method for treating fibrotic diseases or other indications IIIC |
| 05/20/2004 | US20040097494 For use as nitric oxide synthase inhibitors |
| 05/20/2004 | US20040097493 Diazinopyrimidines |
| 05/20/2004 | US20040097487 To inhibits matrix metalloprotease activity |
| 05/20/2004 | US20040097465 ll-12 expression controlling agents |
| 05/20/2004 | US20040097462 Methods and compositions for treating flaviviruses and pestiviruses |
| 05/20/2004 | US20040097457 Protein disulfide isomerase and abc transporter homologous proteins involved in the regulation of energy homeostasis |
| 05/20/2004 | US20040097425 Peptide compounds |
| 05/20/2004 | US20040097420 Proteasome regulation of NF-kB activity |
| 05/20/2004 | US20040097416 Analgesics; neuropathic pain; bipolar disorders |
| 05/20/2004 | US20040097415 Controlling blood glucose concentration; amylin antagonist |
| 05/20/2004 | US20040097407 Method for the synthesis of compounds of formula I and their uses thereof |
| 05/20/2004 | US20040096940 Novel polypeptides having opioid receptor activity, nucleic acids coding therefor and uses thereof |
| 05/20/2004 | US20040096939 Modifier of organelle metabolism |
| 05/20/2004 | US20040096925 Identifying enzyme inhibitors for treatment of skin, allergic and inflammatory disorders; cosmetics |
| 05/20/2004 | US20040096901 Chineric monocllonal antibody for treatment and prevention transplant rejection, psoriasis, inflammatory bowel, autoimmune and allergic disorders |
| 05/20/2004 | US20040096886 Using sodium channel (SCNA) expresion to detect nervous system disorders; antitpileptic agents |